Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Paracetamol IV Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of indicative diseases and conditions
5.1.1.2. Increasing use of paracetamol IV in relieving fever in post-surgical procedures
5.1.1.3. Enhanced usage of acetaminophen to reduce the dependence on opioids for pain management
5.1.2. Restraints
5.1.2.1. Availability of multiple generic products
5.1.3. Opportunities
5.1.3.1. Government initiatives and rising research and development activities
5.1.3.2. Use of paracetamol IV in combination with non-steroidal anti-inflammatory drugs (NSAID) and narcotics
5.1.4. Challenges
5.1.4.1. Lack of experienced healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Paracetamol IV Market, by Indication
6.1. Introduction
6.2. Pain
6.3. Pyrexia/Fever

7. Paracetamol IV Market, by Application
7.1. Introduction
7.2. Non-surgical
7.3. Surgical

8. Paracetamol IV Market, by End-use
8.1. Introduction
8.2. Clinics
8.3. Hospitals

9. Americas Paracetamol IV Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Paracetamol IV Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Paracetamol IV Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aurobindo Pharma Ltd.
13.1.2. Biological E. Limited
13.1.3. Cfl Pharmaceuticals Limited
13.1.4. Changshu Huagang Pharmaceuticals Co., Ltd.
13.1.5. Dr. Reddy’s Laboratories Ltd.
13.1.6. Geno Pharmaceuticals Private Limited
13.1.7. Hebei Jiheng Pharmaceutical Co.,Ltd.
13.1.8. Huzhou Konch Pharmaceutical Co., Ltd.
13.1.9. Lupin Pharmaceuticals, Inc.
13.1.10. Mallinckrodt PLC
13.1.11. Novartis AG
13.1.12. Sanofi S.A.
13.1.13. Sun Pharmaceutical Industries Limited
13.1.14. Teva Pharmaceutical Industries Ltd.
13.1.15. Zhejiang Kangle Pharmaceutical Co., Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. PARACETAMOL IV MARKET RESEARCH PROCESS
FIGURE 2. PARACETAMOL IV MARKET SIZE, 2023 VS 2030
FIGURE 3. PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PARACETAMOL IV MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PARACETAMOL IV MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PARACETAMOL IV MARKET DYNAMICS
FIGURE 7. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PARACETAMOL IV MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. PARACETAMOL IV MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PARACETAMOL IV MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PARACETAMOL IV MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARACETAMOL IV MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. PARACETAMOL IV MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PARACETAMOL IV MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 12. PARACETAMOL IV MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PARACETAMOL IV MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. CANADA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. CANADA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. MEXICO PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. MEXICO PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. CHINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CHINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. INDIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. INDIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. JAPAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. JAPAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. THAILAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. THAILAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. DENMARK PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. DENMARK PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EGYPT PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EGYPT PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. FINLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. FINLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. GERMANY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. ITALY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. ITALY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. NORWAY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. NORWAY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. POLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. POLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. QATAR PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. QATAR PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. TURKEY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. TURKEY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. PARACETAMOL IV MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 142. PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2023
TABLE 143. PARACETAMOL IV MARKET LICENSE & PRICING